Cannasouth has reported a significant increase in group revenues as it begins selling its own-manufactured CBD oral solutions and dried cannabis flower products.
In a trading update, the company revealed that commercial sales of these products commenced in November 2023, following the completion of a verified process by the Medicinal Cannabis Agency.
The revenue figures for the months of October, November, and December 2023, were $26,000, $201,000, and $243,000, respectively.
Cannasouth expressed confidence in the launch of its new products and anticipated further revenue growth as clinics and prescribers gain access to its product range.
See more
